Items tagged with Global health

Unitaid joins UN group on antimicrobial resistance (post)

Geneva, 10 May 2017 – Unitaid has joined the United Nations coordination group on antimicrobial resistance, recognizing the growing public health challenge it poses in the fight against HIV/AIDS, tuberculosis and malaria.

WHO Programme Budget Portal (post)

The World Health Organization (WHO) Programme Budget Portal is a new website providing further details of the Organization’s work, financing and implementation progress.

MSF open letter to G20 Health Ministers highlights 3 global health priority areas (post)

Médecins Sans Frontières: Open letter from MSF to the Meeting of the G20 Health Ministers

World Health Statistics 2017 (post)

Almost half of all deaths globally are now recorded with a cause, new data from WHO show, highlighting improvements countries have made on collecting vital statistics and monitoring progress towards the Sustainable Development Goals (SDGs).

Report outlines priorities for U.S. global health role (post)

New report recommends priority actions to achieve global health security, protect U.S. position as global health leader, and safeguard billions of dollars in health investments.

WHO-commissioned report reflects on achievements, challenges in global health over past decade (post)

WHO: Healthier, fairer, safer: the global health journey 2007-2017

New alliance to drive and measure industry progress to curb antimicrobial resistance (post)

• New Industry Alliance brings together research-based pharmaceutical companies, generics, biotech and diagnostic companies, to drive and measure industry progress to curb antimicrobial resistance.
• The AMR Industry Alliance will ensure that signatories collectively deliver on the commitments made in the Declaration (January 2016) and the Roadmap (September 2016) and will measure industry’s progress in the fight against AMR.
• The Alliance will develop a reporting mechanism to track progress, identify gaps and set targets for the future. Its progress reports will also help to assess what are the key hurdles impeding actions outside of industry’s sole control on reducing antimicrobial resistance and facilitate collaboration between the public and private sector.

Antimicrobial resistance needs new R&D models, NGOs say (post)

A group of non-governmental organisations organised a side event to the World Health Assembly to discuss the growing issue of antimicrobial resistance, the way to incentivise research and development for new antibiotics, and the imperative of affordability and accessibility of new products. The speakers mentioned alternative models, such as delinking the cost of research from the price of the medicines, underlined the high prices of vaccines, and the importance of systems of infection prevention and control.

GHIT Fund secures commitments of over US$200 million to its replenishment for the acceleration of Japanese innovation for infectious diseases of the developing world (post)

This announcement demonstrates the continued leadership and commitment of the Government of Japan, leading life sciences companies, international foundations and other partners to combat neglected diseases; with this replenishment, which marks a doubling of previous commitments, GHIT will accelerate and expand its development of new tools while ensuring they are accessible and delivered to the world’s most vulnerable.

Media coverage of the 70th World Health Assembly (post)

Intellectual Property Watch news coverage of the 70th World Health Assembly: